Panagora Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $239K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $291K | Buy |
|
|||||
|
2022
Q2 | $315K | Hold |
|
|||||
|
2022
Q1 | $351K | Hold |
|
|||||
|
2021
Q4 | $361K | Hold |
|
|||||
|
2021
Q3 | $395K | Sell |
|
|||||
|
2021
Q2 | $686K | Buy |
|
|||||
|
2021
Q1 | $12K | Sell |
|
|||||
|
2020
Q4 | $653K | Hold |
|
|||||
|
2020
Q3 | $596K | Sell |
|
|||||
|
2020
Q2 | $697K | Sell |
|
|||||
|
2020
Q1 | $1.9M | Sell |
|
|||||
|
2019
Q4 | $6.51M | Buy |
|
|||||
|
2019
Q3 | $5.39M | Sell |
|
|||||
|
2019
Q2 | $5.48M | Sell |
|
|||||
|
2019
Q1 | $5.91M | Buy |
|
|||||
|
2018
Q4 | $2.69M | Buy |
|
|||||
|
2018
Q3 | $4.1M | Buy |
|
|||||
|
2018
Q2 | $3.15M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $5.59M | Buy |
|
|||||
|
2017
Q1 | $4.69M | Sell |
|
|||||
|
2016
Q4 | $4.58M | Buy |
|
|||||
|
2016
Q3 | $3.99M | Sell |
|
|||||
|
2016
Q2 | $3.08M | Buy |
|
|||||
|
2016
Q1 | $3.1M | Buy |
|
|||||
|
2015
Q4 | $3.07M | Buy |
|
|||||
|
2015
Q3 | $1.99M | Buy |
|
|||||
|
2015
Q2 | $1.8M | Buy |
|
|||||
|
2015
Q1 | $507K | Buy |
|